EPITA Specialty Update Symposium
SUNDAY 24 SEPTEMBER 2017 | 09:00-12.50
09.00 – 10.40 SESSION 1. New challenges for a fair allocation (recipient)
CHAIRS: Helmut Arbogast, Munich, Germany
Steve White, Newcastle, United Kingdom
09:00 Challenges in different countries. Eurotransplant is in there with the other countries
Eelco de Koning, Leiden, The Netherlands
09:10 Experiences with a common waiting list for islets transplant in the United Kingdom
James Show, United Kingdom
09:25 New allocation system: the Swiss solution
Roger Lehmann, Zurich, Switzerland
09:35 What about France?
Marie-Alice Macher, France
09:50 Pancreas allocation in North Italy Transplant program (NITp)
Massimo Cardillo, Milan, Italy
10:15 The first pancreas transplants were performed 50 years ago.One of the surgeons recalls how it happened and some consequences
Frederick Merkel, Chicago, United States
10.40 – 11.10 Break
11.10 – 12.50 SESSION 2. New challenges in donation (donor)
CHAIRS: Lorenzo Piemonti, Milan, Italy
Johann Pratschke, Berlin, Germany
11:10 What is the crucial information for accepting an organ? Are scoring systems helpful?
Raja Kandaswamy, Minneapolis, United States
11:40 Update on marginal donor utilization
Peter Friend, Oxford, United Kingdom
12:10 Decreasing numbers for beta-cell replacement: what is the reason?
Antonio Secchi, Milan, Italy
OBJECTIVES | To review recent developments in pancreas and islet transplantation.
TARGET AUDIENCE |Transplant surgeons and physicians, transplant coordinator, nurses and medical student with an interest in transplantation of pancreas and islets.
The European Pancreas and Islet Transplantation Association is a section of ESOT founded to provide a Forum for the pancreas and islet transplantation community in Europe.
GOALS |To facilitate the exchange of information of the field of pancreas and islet transplantation.
AIM |The aim of EPITA is to contribute to the development of the pancreas and islet transplantation field and of alternate forms of beta-cell replacement therapy for the benefit of patients suffering from type 1 diabetes.